By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Improving Medication Adherence for Patients with Breast Cancerimage placeholder

Improving Medication Adherence for Patients with Breast Cancer

To meet the essential needs of cancer patients and survivors—including physical, psychological, and social aspects— easily accessible apps providing holistic support have come to the forefront. Of course, for a digital tool to work, patients need to use it. Sidekick Health’s breast cancer program is a transformative force in cancer care, providing a holistic solution that addresses medication adherence, helps with symptom self-management, and promotes wellbeing by deploying behavioral science and gamification principles alongside deep personalization. Download the white paper to see how we achieve industry-leading retention and outcomes.

by
Sidekick Healthcare Team
Be the first to know!
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Thank you! This deep dive is ready to download.
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Download PDF
Oops! Something went wrong while submitting the form.
Be the first to know!
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Thank you! This deep dive is ready to download.
Thank you! This deep dive is ready to watch.
Watch the recording
Oops! Something went wrong while submitting the form.
you may also like
placeholder image
Improving Medication Adherence for Patients with Breast Cancer
placeholder image
Discharge Essentials: Reducing unnecessary readmissions with smart digital support
Cover of Sidekick Health’s whitepaper on FDA’s 2023 draft guidance for Prescription Drug Use-Related Software (PDURS), exploring digital health innovation in Life Sciences across therapeutic areas such as oncology, cardiometabolic conditions, and dermatology.placeholder image
New FDA Guidance On PDURS Ushers In A New Era for Digital Innovation In Life Sciences